Pahl, 2000 - Google Patents
Transplant coronary artery disease in childrenPahl, 2000
View PDF- Document ID
- 9425109509945358818
- Author
- Pahl E
- Publication year
- Publication venue
- Progress in Pediatric cardiology
External Links
Snippet
Transplant coronary artery disease is an accelerated vasculopathy that occurs in adult and pediatric heart transplant recipients, and it is a leading cause of death among late survivors. This form of coronary disease, also known as graft coronary disease, differs from classical …
- 201000008739 coronary artery disease 0 title abstract description 74
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Aranda Jr et al. | Cardiac transplant vasculopathy | |
| Lefèvre et al. | X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial | |
| Pahl et al. | The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study | |
| Conti et al. | Silent ischemia: clinical relevance | |
| Bolderman et al. | Idiopathic renal infarction | |
| Hochman et al. | Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry | |
| Luo et al. | Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation | |
| Esquivel et al. | Transplantation for primary biliary cirrhosis | |
| Blumenthal et al. | Medical therapy versus coronary angioplasty in stable coronary artery disease: a critical review of the literature | |
| Goto et al. | Aortic atherosclerosis and postoperative neurological dysfunction in elderly coronary surgical patients | |
| Manlhiot et al. | Long-term management of Kawasaki disease: implications for the adult patient | |
| Svilaas et al. | Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS)—study design | |
| Bugiardini | Normal coronary arteries: clinical implications and further classification | |
| Rossi et al. | Carotid atherosclerotic plaque instability in patients with acute myocardial infarction | |
| Dent et al. | Transplant coronary artery disease in pediatric heart transplant recipients | |
| Sykora et al. | The mechanism and natural history of mitral regurgitation in cardiac sarcoidosis | |
| Lietz et al. | Current understanding and management of allograft vasculopathy | |
| Pahl | Transplant coronary artery disease in children | |
| Prescott et al. | Design and rationale of FLAVOUR: A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarction | |
| Kala et al. | 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Summary of the document prepared by the Czech Society of Cardiology | |
| Daoulah et al. | Spontaneous coronary artery dissection: does being unemployed matter? Insights from the GSCAD registry | |
| Goldstein | Angiographic plaque complexity: the tip of the unstable plaque iceberg | |
| Potluri et al. | Relationship among epicardial coronary disease, tissue myocardial perfusion, and survival in heart transplantation | |
| Low et al. | Spontaneous coronary artery dissection: clinical implications and diagnostic challenges. Overlooked and underappreciated in Asia? | |
| Méndez-Eirín et al. | Spontaneous coronary artery dissection |